$INFU
InfuSystem Holdings, Inc

2015 Q2 Form 10-Q Financial Statement

#000119312515289989 Filed on August 13, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $16.94M $16.37M
YoY Change 3.47% 11.66%
Cost Of Revenue $4.760M $2.913M
YoY Change 63.41% 2.39%
Gross Profit $12.18M $11.92M
YoY Change 2.16% 15.42%
Gross Profit Margin 71.9% 72.83%
Selling, General & Admin $9.720M $7.522M
YoY Change 29.22% 0.43%
% of Gross Profit 79.8% 63.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $810.0K $100.0K
YoY Change 710.0% 0.0%
% of Gross Profit 6.65% 0.84%
Operating Expenses $10.53M $9.585M
YoY Change 9.86% 1.23%
Operating Profit $1.650M $2.338M
YoY Change -29.43% 171.54%
Interest Expense -$390.0K $776.0K
YoY Change -150.26% -16.02%
% of Operating Profit -23.64% 33.19%
Other Income/Expense, Net $0.00 -$736.0K
YoY Change -100.0% -18.22%
Pretax Income $700.0K $1.602M
YoY Change -56.3% -4207.69%
Income Tax $60.00K $716.0K
% Of Pretax Income 8.57% 44.69%
Net Earnings $640.0K $886.0K
YoY Change -27.77% 743.81%
Net Earnings / Revenue 3.78% 5.41%
Basic Earnings Per Share $0.04
Diluted Earnings Per Share $27.18K $0.04
COMMON SHARES
Basic Shares Outstanding 22.36M shares 22.15M shares
Diluted Shares Outstanding 22.40M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $800.0K $1.000M
YoY Change -20.0% 900.0%
Cash & Equivalents $791.0K $1.041M
Short-Term Investments
Other Short-Term Assets $1.044M $712.0K
YoY Change 46.63% -0.14%
Inventory $1.898M $1.485M
Prepaid Expenses
Receivables $12.30M $10.77M
Other Receivables $0.00 $0.00
Total Short-Term Assets $18.29M $16.30M
YoY Change 12.19% 19.69%
LONG-TERM ASSETS
Property, Plant & Equipment $2.390M $1.577M
YoY Change 51.55% 97.62%
Goodwill $3.585M
YoY Change
Intangibles $26.58M $24.29M
YoY Change 9.46% 0.27%
Long-Term Investments
YoY Change
Other Assets $224.0K $248.0K
YoY Change -9.68% 57.96%
Total Long-Term Assets $73.49M $61.43M
YoY Change 19.63% -1.12%
TOTAL ASSETS
Total Short-Term Assets $18.29M $16.30M
Total Long-Term Assets $73.49M $61.43M
Total Assets $91.78M $77.74M
YoY Change 18.07% 2.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.306M $4.101M
YoY Change 53.77% 6.99%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.744M $3.871M
YoY Change 74.22% 23.91%
Total Short-Term Liabilities $16.24M $10.55M
YoY Change 53.99% 8.28%
LONG-TERM LIABILITIES
Long-Term Debt $28.03M $22.83M
YoY Change 22.8% -9.42%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $28.03M $22.83M
YoY Change 22.8% -9.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.24M $10.55M
Total Long-Term Liabilities $28.03M $22.83M
Total Liabilities $44.27M $33.37M
YoY Change 32.65% -4.49%
SHAREHOLDERS EQUITY
Retained Earnings -$43.34M -$45.59M
YoY Change -4.95% -6.14%
Common Stock $2.000K $2.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.51M $44.36M
YoY Change
Total Liabilities & Shareholders Equity $91.78M $77.74M
YoY Change 18.07% 2.62%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income $640.0K $886.0K
YoY Change -27.77% 743.81%
Depreciation, Depletion And Amortization $810.0K $100.0K
YoY Change 710.0% 0.0%
Cash From Operating Activities $5.180M $2.450M
YoY Change 111.43% 308.33%
INVESTING ACTIVITIES
Capital Expenditures -$5.800M $500.0K
YoY Change -1260.0% -164.1%
Acquisitions
YoY Change
Other Investing Activities -$3.030M $2.760M
YoY Change -209.78% 331.25%
Cash From Investing Activities -$8.830M -$650.0K
YoY Change 1258.46% 306.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.220M -1.250M
YoY Change -197.6% 52.44%
NET CHANGE
Cash From Operating Activities 5.180M 2.450M
Cash From Investing Activities -8.830M -650.0K
Cash From Financing Activities 1.220M -1.250M
Net Change In Cash -2.430M 550.0K
YoY Change -541.82% -244.74%
FREE CASH FLOW
Cash From Operating Activities $5.180M $2.450M
Capital Expenditures -$5.800M $500.0K
Free Cash Flow $10.98M $1.950M
YoY Change 463.08% 41.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22434290 shares
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1041000
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22631950 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22434259 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Inventory Net
InventoryNet
1898000
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12304000
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26584000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
7149000
CY2015Q2 us-gaap Assets
Assets
91779000
CY2015Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2252000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4283000
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3188000
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5635000
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16238000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6306000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43336000
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
4538000
CY2015Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
6744000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
47508000
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
4658000
CY2015Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
28033000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
91779000
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90842000
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3247000
CY2015Q2 us-gaap Liabilities
Liabilities
44271000
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6686000
CY2015Q2 us-gaap Long Term Debt
LongTermDebt
34777000
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4788000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
791000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4319000
CY2015Q2 us-gaap Goodwill
Goodwill
3585000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2390000
CY2015Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
44817000
CY2015Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
13878000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2191000
CY2015Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
150000
CY2015Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1044000
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
224000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
18289000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1894000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4748000
CY2015Q2 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
3959000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14729000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5215000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43705000
CY2015Q2 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
47155000
CY2015Q2 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
24226000
CY2015Q2 infu Medical Equipment Net
MedicalEquipmentNet
26679000
CY2015Q2 infu Long Term Debt Maturities Repayments Of Principal In Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix
10013000
CY2015Q2 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
209000
CY2015Q2 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
18233000
CY2015Q2 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
22720000
CY2015Q2 infu Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Medical Equipment Held For Sale
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSale
1800000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1138000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22506421 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22308730 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3062000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6452000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
46452000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19032000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80213000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90155000
CY2014Q4 us-gaap Liabilities
Liabilities
33761000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
25484000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4739000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
515000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2451000
CY2014Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
42012000
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
13756000
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1194000
CY2014Q4 us-gaap Assets
Assets
80213000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2252000
CY2014Q4 us-gaap Inventory Net
InventoryNet
1758000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10300000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25073000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
633000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
212000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
15458000
CY2014Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2255000
CY2014Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
43246000
CY2014Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
23311000
CY2014Q4 infu Medical Equipment Net
MedicalEquipmentNet
22069000
CY2014Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
121000
CY2014Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
16939000
CY2014Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
19814000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.421 pure
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
261241 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1806000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22321143 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22059902 shares
us-gaap Gross Profit
GrossProfit
23999000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3969000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
33479000
us-gaap Sales Revenue Net
SalesRevenueNet
33614000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2534000
us-gaap Operating Income Loss
OperatingIncomeLoss
4114000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1469000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
29645000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1580000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1746000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
103000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4524000
us-gaap Net Income Loss
NetIncomeLoss
1469000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
35547000
us-gaap Interest Expense
InterestExpense
1603000
us-gaap Operating Expenses
OperatingExpenses
19885000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5279000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5803000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3545000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1254000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-97000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1065000
us-gaap Depreciation
Depreciation
200000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1384000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-519000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4005000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9807000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
32198000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1500000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
3812000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
dei Trading Symbol
TradingSymbol
INFU
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.397 pure
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
398639 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3787000
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2020-03-23
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22743948 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
dei Entity Central Index Key
EntityCentralIndexKey
0001337013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22345309 shares
us-gaap Gross Profit
GrossProfit
23943000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3140000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
43586000
us-gaap Sales Revenue Net
SalesRevenueNet
33895000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
230000
us-gaap Operating Income Loss
OperatingIncomeLoss
2869000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
368000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
30755000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2639000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
575000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
3786000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
48000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
157000
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22146106 shares
CY2014Q2 us-gaap Gross Profit
GrossProfit
11923000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
51546000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
2100000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9474000
us-gaap Net Income Loss
NetIncomeLoss
368000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1599000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
35088000
us-gaap Interest Expense
InterestExpense
1059000
us-gaap Operating Expenses
OperatingExpenses
21074000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5424000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6671000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2337000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1344000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
276000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-138000
us-gaap Depreciation
Depreciation
200000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7873000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11384000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1876000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
118000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11969000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
3281000
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
253328 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22399434 shares
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-736000
CY2014Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1024000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
886000
CY2014Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
17336000
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1577000
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
16372000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1602000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2338000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
886000
CY2014Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
14795000
CY2014Q2 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
800000
CY2014Q2 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1536000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
443478 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22824965 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22381487 shares
us-gaap Gross Profit
GrossProfit
11854000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1554000
us-gaap Sales Revenue Net
SalesRevenueNet
17170000
CY2014Q2 us-gaap Interest Expense
InterestExpense
776000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
9585000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
930000
us-gaap Operating Income Loss
OperatingIncomeLoss
1317000
us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
100000
us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
200000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
783000
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2624000
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2913000
CY2014Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1438000
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
625000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
716000
CY2014Q2 us-gaap Depreciation
Depreciation
100000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4898000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
15616000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-387000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
829000
us-gaap Net Income Loss
NetIncomeLoss
783000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
17566000
us-gaap Interest Expense
InterestExpense
387000
us-gaap Operating Expenses
OperatingExpenses
10537000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2687000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3656000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1143000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
713000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
147000
us-gaap Depreciation
Depreciation
100000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5994000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1100000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1660000

Files In Submission

Name View Source Status
0001193125-15-289989-index-headers.html Edgar Link pending
0001193125-15-289989-index.html Edgar Link pending
0001193125-15-289989.txt Edgar Link pending
0001193125-15-289989-xbrl.zip Edgar Link pending
d29678d10q.htm Edgar Link pending
d29678dex311.htm Edgar Link pending
d29678dex312.htm Edgar Link pending
d29678dex321.htm Edgar Link pending
d29678dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g29678tx_logo.jpg Edgar Link pending
infu-20150630.xml Edgar Link completed
infu-20150630.xsd Edgar Link pending
infu-20150630_cal.xml Edgar Link unprocessable
infu-20150630_def.xml Edgar Link unprocessable
infu-20150630_lab.xml Edgar Link unprocessable
infu-20150630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending